Home / Healthcare/ Sanofi and partner seek European Medicines Agency review for sleep sickness product

Sanofi and partner seek European Medicines Agency review for sleep sickness product


Comments / {{hitsCtrl.values.hits}} Views / Friday, 2 February 2018 00:00


PARIS (Reuters): French healthcare group Sanofi, along with its business partner, has asked the European Medicines Agency (EMA) to review the fexinidazole product for the treatment of sleeping sickness, the company said on Wednesday.

Fexinidazole is being developed in collaboration with the Drugs for Neglected Disease initiative (DNDi), a not-for-profit research organization.

It would be the first all-oral treatment under examination for Trypanosoma brucei gambiense human African trypanosomiasis (g-HAT), commonly known as sleeping sickness which affects many in Africa, added Sanofi.

The EMA has accepted the application under a special procedure called “Article 58” which allows the EMA to give a scientific opinion, in co-operation with the World Health Organization, for the evaluation of medicinal products intended exclusively for markets outside of the European Union.

Human African Trypanosomiasis (HAT) or “sleeping sickness” is a tropical disease affecting sub-Saharan African countries.

 


Share This Article


DISCLAIMER:

1. All comments will be moderated by the Daily FT Web Editor.

2. Comments that are abusive, obscene, incendiary, defamatory or irrelevant will not be published.

3. We may remove hyperlinks within comments.

4. Kindly use a genuine email ID and provide your name.

5. Spamming the comments section under different user names may result in being blacklisted.

COMMENTS

Today's Columnists

Relevance of brand valuation?

Thursday, 22 November 2018

Another iconic global business leader has been exposed. Greed, both personal and corporate, it seems is the root cause. This mirrors the conduct of many political leaders around the world. Is it time to have much greater checks on CEOs, may be power-


JVP and minorities: Towards a third way

Thursday, 22 November 2018

As Sri Lanka moves toward a political show down between the UNP and SLFP/SLPP traditional political rivals, there is a third force with great potential strength emerging as a decider in any final outcome, provided that force remains united. By this


Reaching global quality standards through Deming Award

Wednesday, 21 November 2018

The importance of quality in the contemporary competitive business environment cannot be over-emphasised. Total Quality Management (TQM)is a company-wide, all pervasive management philosophy, which organisations globally, in many business sectors hav


Ramsar accreditation of Colombo Wetlands: Rebranding Colombo as a Wetland City

Wednesday, 21 November 2018

Colombo, once known to be “kolonthota,” has always been identified as a wetland complex at the heart of the Kelani river delta. Today this city is increasingly drying up, with around 20 sq km left as wetlands which continue to be threatened every


Columnists More